https://m2.mtmt.hu/ hun 2026-04-30 05:40 JournalArticle 36983440 APPROVED true 0 false 2026-03-02T07:19:39.482+0000 2026-03-02T07:18:39.741+0000 2026-03-02T07:18:35.067+0000 true 10103105 Mátics Bernadett /api/admin/10103105 Admin Mátics Bernadett (OOI admin5) true 2026-03-02T07:18:39.757+0000 2026-03-02T07:18:39.757+0000 true true true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Küronya, Zsófia true true /api/journal/10012929 REVIEWED JOURNAL OF MEDICAL CASE REPORTS 1752-1947 true false 10012929 false 10012929 true 1752-1947 Journal FOREIGN 2026 true 2026 true true true false true false GOLD 2026-03-02 false http://jmedicalcasereports.com/ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3 false false false false 2026-05-31T06:18:39.556+0000 Országos Onkológiai Intézet 3 6 1 5 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 134405601 /api/authorship/134405601 Küronya, Zsófia [Küronya, Zsófia (klinikai onkológia), szerző] Országos Onkológiai Intézet 1 0.2 true false false Author 10061833 /api/author/10061833 Küronya Zsófia (klinikai onkológia) Küronya Zsófia true 10061833 true Küronya Zsófia true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 134405602 /api/authorship/134405602 Lénárt, Enikő 2 0.2 false false false Lénárt Enikő true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 134405603 /api/authorship/134405603 Soós, Edina 3 0.2 false false false Soós Edina true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 134405604 /api/authorship/134405604 Géczi, Lajos [Géczi, Lajos (Onkológia), szerző] Országos Onkológiai Intézet 4 0.2 false false false Author 10034949 /api/author/10034949 Géczi Lajos (Onkológia) Géczi Lajos true 10034949 true Géczi Lajos true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 134405605 /api/authorship/134405605 Biró, Krisztina [Bíró, Krisztina (Orvostudomány), szerző] Országos Onkológiai Intézet 5 0.2 false true false Author 10053048 /api/author/10053048 Bíró Krisztina (Orvostudomány) Bíró Krisztina true 10053048 true Biró Krisztina true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 31559600 /api/publicationidentifier/31559600 DOI: 10.1186/s13256-026-05886-3 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true 10.1186/s13256-026-05886-3 https://doi.org/10.1186/s13256-026-05886-3 false true PublicationIdentifier 31559601 /api/publicationidentifier/31559601 Egyéb URL: https://link.springer.com/10.1186/s13256-026-05886-3 PlainSource 40 /api/publicationsource/40 Egyéb URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true https://link.springer.com/10.1186/s13256-026-05886-3 https://link.springer.com/10.1186/s13256-026-05886-3 false true SjrRating 11703054 /api/sjrrating/11703054 sjr:Q3 (2026) Scopus - Medicine (miscellaneous) JOURNAL OF MEDICAL CASE REPORTS 1752-1947 1718 0.74 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2701 /api/classificationexternal/2701 Scopus - Medicine (miscellaneous) true 2701 true Q3 FROM_PREVIOUS_TO_LAST_YEAR true true Reference 73099725 /api/reference/73099725 1. Xu W, Atkins MB, McDermott DF. Checkpoint inhibitor immunotherapy in kidney cancer. Nat Rev Urol. 2020;17(3):137–50., DOI: 10.1038/s41585-020-0282-3 1 10.1038/s41585-020-0282-3 false true Reference 73099726 /api/reference/73099726 2. Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1803–13., DOI: 10.1056/NEJMoa1510665 2 10.1056/NEJMoa1510665 false true Reference 73099727 /api/reference/73099727 3. Elias R, Yan F, Singla N, Levonyack N, Formella J, Christie A, et al. Immune related adverse events are associated with improved outcomes in ICI treated renal cell carcinoma patients. J Clin Oncol. 2019;37(7_suppl):645–645., DOI: 10.1200/JCO.2019.37.7_suppl.645 3 10.1200/JCO.2019.37.7_suppl.645 false true Reference 73099728 /api/reference/73099728 4. Washino S, Shirotake S, Takeshita H, Inoue M, Miura Y, Hyodo Y, et al. Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis. Int J Clin Oncol. 2023;28(12):1651–8., DOI: 10.1007/s10147-023-02406-x 4 10.1007/s10147-023-02406-x false true Reference 73099729 /api/reference/73099729 5. Schneider BJ, Naidoo J, Santomasso BD, Lacchetti C, Adkins S, Anadkat M, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J Clin Oncol. 2021;39(36):4073–126., DOI: 10.1200/JCO.21.01440 5 10.1200/JCO.21.01440 false true Reference 73099730 /api/reference/73099730 6. Chang E, Zhou J, Song C, Gittleman H, Fernandes L, Weinstock C, et al. A pooled analysis of treatment-free survival in advanced renal cell carcinoma. Clin Cancer Res. 2024;30(15):3282–6., DOI: 10.1158/1078-0432.CCR-23-3719 6 10.1158/1078-0432.CCR-23-3719 false true Reference 73099731 /api/reference/73099731 7. Regan MM, Jegede OA, Mantia CM, Powles T, Werner L, Motzer RJ, et al. Treatment-free survival after immune checkpoint inhibitor therapy versus targeted therapy for advanced renal cell carcinoma: 42-month results of the checkmate 214 trial. Clin Cancer Res. 2021;27(24):6687–95., DOI: 10.1158/1078-0432.CCR-21-2283 7 10.1158/1078-0432.CCR-21-2283 false true Reference 73099732 /api/reference/73099732 8. Kurahashi R, Motoshima T, Fukushima Y, Murakami Y, Yatsuda J, Yamaguchi T, et al. Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide-based vaccine. IJU Case Reports. 2020;3(2):44–8., DOI: 10.1002/iju5.12139 8 10.1002/iju5.12139 false true Reference 73099733 /api/reference/73099733 9. Vuyyala S, Gandhi S, Kuechle JB, George S. Complete remission of bone metastases in renal cell carcinoma with nivolumab. Cureus. 2019. https://doi.org/10.7759/cureus.5531., DOI: 10.7759/cureus.5531 9 10.7759/cureus.5531 false true /api/publication/36983440 Küronya Zsófia et al. Sustained complete remission with third-line nivolumab in advanced renal cell carcinoma: a case report. (2026) JOURNAL OF MEDICAL CASE REPORTS 1752-1947<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10061833"><a href="/gui2/?type=authors&mode=browse&sel=10061833" target="_blank">Küronya Zsófia (<span class="authorship-author-name">Küronya Zsófia</span> <span class="authorAux-mtmt"> klinikai onkológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Lénárt Enikő </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Soós Edina </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10034949"><a href="/gui2/?type=authors&mode=browse&sel=10034949" target="_blank">Géczi Lajos (<span class="authorship-author-name">Géczi Lajos</span> <span class="authorAux-mtmt"> Onkológia</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10053048"><a href="/gui2/?type=authors&mode=browse&sel=10053048" target="_blank">Biró Krisztina (<span class="authorship-author-name">Bíró Krisztina</span> <span class="authorAux-mtmt"> Orvostudomány</span>) </a> </span> <span class="author-affil">Országos Onkológiai Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36983440" target="_blank">Sustained complete remission with third-line nivolumab in advanced renal cell carcinoma: a case report</a></div> <div> <span class="journal-title">JOURNAL OF MEDICAL CASE REPORTS</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/1752-1947">1752-1947</a>)</span>: <span class="journal-volume"></span> <span class="page"> </span> <span class="year">(2026)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:black" title="10.1186/s13256-026-05886-3" target="_blank" href="https://doi.org/10.1186/s13256-026-05886-3"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="https://link.springer.com/10.1186/s13256-026-05886-3" target="_blank" href="https://link.springer.com/10.1186/s13256-026-05886-3"> Egyéb URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q3</div> </div></OnlyViewableByAuthor> <div class="mtid"><span class="long-pub-mtid">Közlemény: 36983440</span> | <span class="status-data status-APPROVED"> Nyilvános </span> Forrás | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData"></span> </div> <div class="lastModified">Utolsó módosítás: 2026.03.02. 08:18 Mátics Bernadett (OOI admin5) </div> </div></div>